← Back to Search

Community Resilience Program for Community Violence

N/A
Waitlist Available
Led By Elizabeth Miller, MD, PhD
Research Sponsored by University of Pittsburgh
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Timeline
Screening 3 weeks
Treatment Varies
Follow Up change from 1 year period before baseline to approximately 2 years after baseline
Awards & highlights

Study Summary

This trial will test how well a community program can reduce violence by helping people to be strong and resilient.

Who is the study for?
This trial is for youth (13 years and older) and adults of all genders who live in specific neighborhoods chosen for the study. It's not open to anyone younger than 13 or those living outside these neighborhoods.Check my eligibility
What is being tested?
The study tests a community intervention called CRCEI aimed at increasing resilience and reducing violence, compared with standard health education sessions. Participants are grouped by neighborhood and randomly assigned to one of the interventions.See study design
What are the potential side effects?
Since this trial involves community-based interventions rather than medical treatments, traditional side effects are not applicable. However, participants may experience changes in their perception of community safety or personal well-being.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~change from 1 year period before baseline to approximately 2 years after baseline
This trial's timeline: 3 weeks for screening, Varies for treatment, and change from 1 year period before baseline to approximately 2 years after baseline for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Change from baseline in perceptions of neighborhood collective efficacy and community cohesion
Secondary outcome measures
Change from baseline in collective efficacy and neighborhood social norms
Community incidence of violence in 12 month period
Number of self-reported events of violence exposure

Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: Community Resiliency Collective Efficacy Intervention (CRCEI)Experimental Treatment1 Intervention
Community Resiliency Collective Efficacy Intervention (CRCEI) to engage community members in dialogue on thriving, community leadership, and organizing for social change (9 sessions).
Group II: Health Education SessionsActive Control1 Intervention
Comparison neighborhoods will receive health education sessions as a control intervention. (9 sessions)

Find a Location

Who is running the clinical trial?

University of PittsburghLead Sponsor
1,723 Previous Clinical Trials
16,338,556 Total Patients Enrolled
Centers for Disease Control and PreventionFED
875 Previous Clinical Trials
22,472,802 Total Patients Enrolled
Elizabeth Miller, MD, PhDPrincipal InvestigatorUniversity of Pittsburgh
8 Previous Clinical Trials
30,912 Total Patients Enrolled

Media Library

Community Resiliency Collective Efficacy Intervention (CRCEI) Clinical Trial Eligibility Overview. Trial Name: NCT05768217 — N/A
Physical Violence Research Study Groups: Community Resiliency Collective Efficacy Intervention (CRCEI), Health Education Sessions
Physical Violence Clinical Trial 2023: Community Resiliency Collective Efficacy Intervention (CRCEI) Highlights & Side Effects. Trial Name: NCT05768217 — N/A
Community Resiliency Collective Efficacy Intervention (CRCEI) 2023 Treatment Timeline for Medical Study. Trial Name: NCT05768217 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Is this investigation still recruiting volunteers?

"According to clinicaltrials.gov, this particular medical trial has ceased recruitment for patients. It was initially posted on March 1st 2024 and last updated on the 12th of March 2023. However, there are 44 other studies actively recruiting at present."

Answered by AI
~3067 spots leftby Sep 2026